← Open Payments lookup

MANJIT SANGHA: Open Payments

NPI 1447661871 · GLEN ALLEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$893 in 34 payments from 9 companies in 2025. Trend: 2023 $1,247 · 2024 $409 · 2025 $893

Food & beverage: $893
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$252
E.R. Squibb & Sons, L.L.C.7$197
Teva Pharmaceuticals USA, Inc.4$178
ABBVIE INC.5$92
Neurocrine BioSciences, Inc.2$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
Takeda Pharmaceuticals U.S.A., Inc.2$34
Lundbeck LLC1$29
Neos Therapeutics, LP1$16

Products named: REXULTI, COBENFY, AUSTEDO XR, VRAYLAR, INGREZZA, CAPLYTA, TRINTELLIX, Adzenys XR-ODT.

Industry payments across VA — which companies pay providers there.